ARCHIVES

Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study

This article is from The Cancer Letter archive.

Vol. 31 No. 5 | May 30, 2008

Download PDF Visit The Full Archive

Related Articles

NCAB Member Pollin Organizes Minority Outreach Effort

January 4, 1991

FDA Approves Molecular Test For Breast Cancer Detection

July 27, 2007

Exercise May Help Combat Leukemia Patients’ Fatigue

August 28, 2009

Behavior Scientists To Discuss Cancer Patient Rehabilitation

January 17, 1975

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

January 25, 2002

DCCPT Board, NCAB Approve Core Grant Guideline Changes, Consortium Centers

May 17, 1985